Catherine Longworth, Author at

The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare.

Keeping clinical trial data safe – handling cybersecurity in a risky world

https://pharmaphorum.com/views-and-analysis/keeping-clinical-trial-data-safe-handling-cybersecurity-in-a-risky-world/

mapping the path to better communication outcomes

News/ News

90TEN expands senior leadership with new promotions

Catherine Longworth 90TEN, comms, Envision Pharma Group 0 Comment

London-based healthcare communications consultancy 90TEN is expanding its senior leadership team with a new hire and two promotions.

90TEN expands senior leadership with new promotions

https://pharmaphorum.com/r-d/news-r-d/90ten-claire-long-and-sabrina-gomersall-to-lead-communications/

Sales and Marketing/ Views & Analysis/ Views and analysis

Pricing, Profits and Progress: Pharma’s Post-COVID Priorities

Catherine Longworth Drug pricing, profits 0 Comment

As post-pandemic recovery begins, big pharma remains in the spotlight. Jesse Mendelsohn explores pharma’s priorities on pricing, profits and

Pricing, Profits and Progress: Pharma’s Post-COVID Priorities

https://pharmaphorum.com/views-and-analysis/pricing-profits-and-progress-pharmas-post-covid-priorities/

News/ News/ R&D

The Bloc hires Stuart Goldstein as COO

Catherine Longworth comms, digital agency, sales, The Bloc 0 Comment

Stuart Goldstein has been hired as the chief operating officer at New-York-based healthcare creative agency The Bloc. In

The Bloc hires Stuart Goldstein as COO

https://pharmaphorum.com/news/the-bloc-hires-stuart-goldstein-as-coo/

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Oncology/ Views & Analysis/ Views and analysis

Changing focus to cachexia may be key to improved cancer outcomes

Catherine Longworth cachexia, cancer, immunotherapy, Oncology 0 Comment

Cachexia could be the next blockbuster area in cancer therapeutics because of its link to survival outcomes. Physician

Changing focus to cachexia may be key to improved cancer outcomes

https://pharmaphorum.com/views-analysis-oncology/changing-focus-to-cachexia-may-be-key-to-improved-cancer-outcomes/

Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Are microtaggants the key to making medicines smarter?

Catherine Longworth counterfeiting, microtaggants, security, smart medicines 0 Comment

Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of

Are microtaggants the key to making medicines smarter?

https://pharmaphorum.com/views-and-analysis/are-microtaggants-key/

Close-up image of a firm handshake between two colleagues

News/ News/ Sales and Marketing

Ashfield Engage acquires US consulting firm Nuvera LLC

Catherine Longworth Ashfield Engage, comms, M&A, Nuvera 0 Comment

Ashfield Engage has completed the acquisition of Nuvera, a US-based healthcare consulting firm specialising in patient support programmes.

Ashfield Engage acquires US consulting firm Nuvera LLC

https://pharmaphorum.com/news/ashfield-engage-acquires-nuvera/

News/ News/ R&D

Novo Holdings co-leads $200m financing into Esco Lifesciences

Catherine Longworth asia, Esco, Novo Holdings, private financing, Singapore 0 Comment

Life sciences tools company Esco Lifesciences Group has scored $200m in a series A and crossover round co-led

Novo Holdings co-leads $200m financing into Esco Lifesciences

https://pharmaphorum.com/news/novo-holdings-leads-200m-financing-round-in-esco-lifesciences-group/

Digital/ News/ News

Axtria scores $150m investment from Bain Capital Tech Opportunities

Catherine Longworth Axtria, Bain Capital Opportunities, comms 0 Comment

Life sciences software company Axtria has received a $150 million investment from Bain Capital Tech Opportunities to expand

Axtria scores $150m investment from Bain Capital Tech Opportunities

https://pharmaphorum.com/news/axtria-scores-150m-investment-from-bain-capital-tech-opportunities/

Trending

About Catherine Longworth

Posts by Catherine Longworth:

Keeping clinical trial data safe – handling cybersecurity in a risky world

90TEN expands senior leadership with new promotions

Pricing, Profits and Progress: Pharma’s Post-COVID Priorities

The Bloc hires Stuart Goldstein as COO

Changing focus to cachexia may be key to improved cancer outcomes

Are microtaggants the key to making medicines smarter?

Ashfield Engage acquires US consulting firm Nuvera LLC

Novo Holdings co-leads $200m financing into Esco Lifesciences

Axtria scores $150m investment from Bain Capital Tech Opportunities

Trending

About Catherine Longworth

Posts by Catherine Longworth:

Login